Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness.
Fracasso G, Falvo E, Colotti G, Fazi F, Ingegnere T, Amalfitano A, Doglietto GB, Alfieri S, Boffi A, Morea V, Conti G, Tremante E, Giacomini P, Arcovito A, Ceci P.
Fracasso G, et al. Among authors: colotti g.
J Control Release. 2016 Oct 10;239:10-8. doi: 10.1016/j.jconrel.2016.08.010. Epub 2016 Aug 12.
J Control Release. 2016.
PMID: 27524282